Form 4 holding
CTO/CSO
Oncternal Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 44,019
- Estimated value
- $21,838
- Report date
- 03 Jan 2024
- Price
- $0.4961
- Ownership
- Direct
Rajesh Krishnan - CTO/CSO at Oncternal Therapeutics, Inc.
Issuer-level insider activity
- Role
- Cto/Cso
- Issuer ticker
- ONCT
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Rajesh Krishnan since 14 Oct 2025
Reported holdings for Rajesh Krishnan in Oncternal Therapeutics, Inc.
Form 4 holding
CTO/CSO
Oncternal Therapeutics, Inc.
- Security class
- Stock Option
- Shares / value
- 17,700
- Estimated value
- Report date
- 14 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Rajesh Krishnan in Oncternal Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.